Two studies from Greece, a non-TB endemic country per the WHO classification, demonstrated that about a third of patients with rheumatic diseases treated with TNF-alpha inhibitors or other biologics had initial negative LTBI screening tests that later converted to a positive screen [7, 8]. The gene discussed is TNF; the disease is rheumatic disorder.